Publication | Open Access
Baseline Characteristics and Survival of Adult Severe Sepsis Patients Treated With Drotrecogin Alfa (Activated) in a Global, Single-Arm, Open-Label Trial (ENHANCE
14
Citations
0
References
2003
Year
Open-label TrialAcute CareClinical TrialsSepsisTranslational ResearchSepsis PhenotypingPharmacotherapyBaseline CharacteristicsMedicineDrotrecogin AlfaCritical Emergency Medicine
No additional data available for this publication yet. Check back later!